U.S. vs Universal Healthcare: Mortality Rates and Care Quality

Quick answer: The United States spends roughly 2.5 times the OECD average per person on health care, yet Americans die younger than residents of almost every other wealthy nation. U.S. life expectancy hit a record 79.0 years in 2024, still about two years below the OECD average. However, universal systems carry their own costs, especially long waits for elective surgery and diagnostic imaging.

Key Takeaways

• Spending: The U.S. spent $14,885 per person on health care, compared with an OECD average of $5,967 (OECD Health at a Glance 2025).
• Life expectancy: Americans reached 79.0 years in 2024, a national record, yet still third-lowest among OECD countries studied by the Commonwealth Fund.
• Avoidable deaths: U.S. avoidable mortality ranks second-highest among the OECD nations analyzed, behind only Mexico.
• Maternal deaths: The U.S. recorded 17.9 maternal deaths per 100,000 live births in 2024. Eleven peer nations report fewer than five.
• U.S. strengths: Cancer survival, specialist access, and elective surgery waits rank among the best in the world.
• Universal system weaknesses: England’s NHS carried roughly 7.1 million treatment cases in 2026. Canadian patients waited a median 28.6 weeks from referral to treatment in 2025.
• The nuance: Drug overdoses, firearms, and car crashes explain a large share of the U.S. mortality gap, and none of those sit squarely inside the health system.

What Does “Universal Healthcare” Actually Mean?

Universal healthcare means every resident holds coverage for essential medical services. It does not mean one specific system. Countries reach that goal through at least three distinct models.

Single-Payer Systems

The government funds care through taxes and pays providers directly. Canada and the United Kingdom follow this approach. Patients face little or no cost at the point of care.

Social Health Insurance

Germany, France, and Japan use regulated nonprofit or quasi-public insurers. Employers and workers fund the system through payroll contributions. Meanwhile, the government sets prices and caps out-of-pocket spending.

Regulated Private Insurance

Switzerland and the Netherlands require every resident to buy private coverage. Insurers must accept all applicants. In addition, subsidies protect lower-income households.

Why this matters: Critics often equate universal coverage with British-style waiting lists. Yet Germany, the Netherlands, and Switzerland deliver universal coverage with short waits. Therefore, long queues reflect specific design and funding choices rather than universal coverage itself.

How Much Does the U.S. Spend Compared With Universal Systems?

The United States outspends every other country by a wide margin, and that gap keeps widening.

The Commonwealth Fund reports that the U.S. devoted 18% of GDP to health care in 2024. By comparison, the average OECD country spent roughly half that share. Per-person spending ran 1.5 times higher than second-place Switzerland.

Sources: OECD Health at a Glance 2025; Commonwealth Fund, U.S. Health Care from a Global Perspective, May 2026.

Higher spending buys more MRI scanners and faster specialist appointments. Still, it does not buy more doctors, more hospital beds, or longer lives.

Mortality Rates: U.S. vs Universal Healthcare Countries

Mortality data tells the clearest story in this comparison. Across nearly every headline measure, the U.S. trails peer nations that guarantee coverage.

Life Expectancy

U.S. life expectancy reached 79.0 years in 2024, according to CDC’s National Center for Health Statistics. That figure marked an all-time high and a 0.6-year gain over 2023. Falling overdose deaths drove much of the improvement.

Nevertheless, the record still leaves the U.S. behind. The Commonwealth Fund places American life expectancy about two years below the OECD average. Switzerland leads at 84.3 years, followed by Japan at 84.1 and Spain at 84.0.

Internal gaps widen the picture further. Non-Hispanic Black Americans lived 74 years on average in 2023. American Indian and Alaska Native Americans lived just 70.1 years.

Avoidable Mortality

Researchers split avoidable deaths into two buckets. Preventable deaths respond to public health action. Treatable deaths respond to timely medical care.

A 2025 study in JAMA Internal Medicine tracked both across 40 high-income countries. Between 2009 and 2019, avoidable mortality rose in every single U.S. state, by a median of 29 deaths per 100,000. Meanwhile, most comparator countries cut theirs by a median of 14.4 deaths per 100,000.

Drug overdoses drove roughly 70% of the increase in preventable deaths. Consequently, the U.S. now ranks second-worst on avoidable mortality among OECD nations in the Commonwealth Fund’s 2026 analysis.

Infant Mortality

The U.S. recorded 5.5 infant deaths per 1,000 live births in 2024. That rate held steady from 2023. By contrast, Japan, Finland, Norway, and Sweden all report rates near or below 2 per 1,000.

Maternal Mortality

American maternal deaths fell slightly to 17.9 per 100,000 live births in 2024, down from 18.6 in 2023. However, CDC classified that change as statistically insignificant.

The racial gap remains stark. Black women died at 44.8 per 100,000, roughly three times the rate for White women at 14.2. Meanwhile, 11 of 18 peer countries studied by the Commonwealth Fund report fewer than five maternal deaths per 100,000.

Where the U.S. System Performs Well

A fair comparison must acknowledge real American strengths. The U.S. leads or nearly leads on several important quality measures.

Cancer Survival

The CONCORD-3 study analyzed 37.5 million cancer patients across 71 countries. For most cancers, five-year net survival ranked among the world’s highest in the U.S., Canada, Australia, New Zealand, and the Nordic nations. U.S. five-year breast cancer survival reached 90.2%.

That said, researchers urge caution. Aggressive screening detects more early-stage and slow-growing tumors. As a result, survival statistics partly reflect earlier diagnosis rather than better treatment alone.

Speed of Specialist and Surgical Access

Americans wait far less than Canadians for specialists and elective procedures. Commonwealth Fund surveys have consistently found that most U.S. patients see a specialist within four weeks. In Canada, fewer than half manage that.

Care Process Quality

The Commonwealth Fund’s Mirror, Mirror 2024 report ranked the U.S. last overall among 10 wealthy nations. Yet the same report ranked the U.S. second on care process, which covers prevention, safety, coordination, and patient engagement.

In other words, Americans who reach the system often receive excellent care. The problem sits upstream, at access and affordability.

Patient-Clinician Relationships

Most Americans with a regular doctor report a strong relationship with that clinician. Specifically, they say their doctor explains clearly, involves them in decisions, and gives them enough time. Canadian patients reported the weakest such relationships in the Commonwealth Fund’s 2026 comparison.

Where Universal Healthcare Systems Struggle

Universal coverage solves the affordability problem. However, it does not automatically solve capacity.

The NHS Backlog in England

England’s waiting list for planned hospital treatment stood at roughly 7.1 million cases in 2026. That total fell from a 2023 peak of 7.7 million, so the trend has improved. Even so, about 2.5 million patients waited longer than 18 weeks, and roughly 111,000 waited more than a year.

Median waits tell a similar story. Patients waited about 12 weeks in 2026, compared with 7.3 weeks before the pandemic.

Canadian Wait Times

The Fraser Institute surveyed 1,577 Canadian physicians for its 2025 report. They reported a median 28.6-week wait from GP referral to treatment. That total splits into 15.3 weeks to see a specialist, then 13.3 weeks to receive treatment.

Diagnostic delays compound the problem. Patients waited a median 18.1 weeks for an MRI and 8.8 weeks for a CT scan. Meanwhile, neurosurgery patients waited 49.9 weeks and orthopedic patients waited 48.6 weeks.

Workforce and Capacity Pressure

Aging populations strain every system. Additionally, physician burnout and staff shortages affect universal and market-based systems alike. Several universal countries now contract private hospitals to clear surgical backlogs.

The Important Caveat

Canada and the U.K. sit at the extreme end of the waiting-time spectrum. By contrast, Germany, the Netherlands, and Switzerland combine universal coverage with quick access. Therefore, “universal coverage causes long waits” oversimplifies the evidence considerably.

Does Universal Coverage Actually Reduce Mortality?

This question sits at the heart of the debate, and the evidence points in one direction while carrying real uncertainty.

About 27 million Americans, roughly 8% of the population, carry no health insurance at all. Another quarter hold plans with deductibles high enough to deter care. As a result, Americans skip needed treatment at higher rates than residents of any peer nation.

A Yale School of Public Health team modeled a single-payer transition in a July 2026 preprint. They projected 114,174 fewer deaths per year alongside $1.04 trillion in annual savings. That analysis updates a 2020 Lancet study, which projected 68,000 lives saved and $450 billion in savings.

Importantly, the authors flag their own limitations. Direct mortality estimates for underinsured adults do not exist, so the team modeled that risk. Their cost figures also exclude transition costs and provider payment responses. The paper has not yet completed peer review.

Coverage losses cut the other way. Commonwealth Fund analysts, citing CBO projections, estimate that recent federal changes will add 17 million uninsured Americans by 2034. Separately, Yale researchers warned in 2025 that proposed Medicaid and marketplace changes could produce more than 51,000 preventable deaths per year.

Why the U.S. Mortality Gap Is Not Only a Healthcare Problem

Blaming the insurance system for every excess American death misreads the data. Several major killers sit largely outside clinical medicine.

A Johns Hopkins analysis compared the U.S. with England and Wales. Four preventable causes explained the entire 2.7-year life expectancy gap:

• Cardiovascular disease: U.S. death rates run 38% higher.
• Drug overdoses: roughly 32% of the gap.
• Firearm deaths: roughly 20% of the gap.
• Motor vehicle crashes: roughly 17% of the gap.

The AAMC reached a similar conclusion. If alcohol, drug, and firearm deaths disappeared entirely, U.S. life expectancy would rise by about 1.6 years.

Obesity adds further weight. Americans carry higher rates of obesity, diabetes, and hypertension than nearly all peer nations, and those conditions arrive earlier in life.

The honest synthesis: Universal coverage would likely narrow the gap. Yet it would not close it. Gun policy, road safety, addiction treatment, and food environments all sit on the critical path.

Cost: Would Universal Coverage Cost More or Less?

Cost estimates appear to contradict each other. In reality, they usually measure different things.

Single-payer proposals shift spending from premiums and out-of-pocket costs onto the federal budget. Therefore, federal spending rises sharply even when total national spending falls. Notably, the Mercatus analysis itself projected slightly lower national health spending under the Sanders plan.

The practical disagreement centers on assumptions. How far would provider payment rates fall? How much administrative overhead would disappear? How would hospitals respond? Small changes to those inputs swing the totals by trillions.

The Debate in Brief

The Case for Universal Coverage

Supporters point to the outcome data. Every peer nation covers everyone, spends far less, and posts better mortality numbers. Furthermore, medical debt barely exists elsewhere. Advocates argue that guaranteed coverage removes the cost barrier that pushes Americans to delay care until conditions worsen.

The Case Against a U.S. Single-Payer Transition

Opponents raise four main objections. First, a federal takeover would require historic tax increases. Second, price controls could reduce investment in new drugs and devices, where the U.S. currently leads. Third, capacity constraints could import Canadian-style waits. Fourth, they argue that overdoses, firearms, and obesity drive the mortality gap, so insurance reform alone would deliver less than advocates promise.

Middle-Ground Reforms

Many analysts favor incremental options instead. These include a public insurance option, automatic enrollment, Medicaid expansion in the 10 remaining holdout states, capped out-of-pocket costs, and stronger price regulation. Germany, the Netherlands, and Switzerland show that universal coverage can coexist with private insurers.

Frequently Asked Questions

Does universal healthcare lower mortality rates?

Countries with universal coverage generally post lower avoidable mortality, lower infant mortality, and longer life expectancy than the U.S. Modeling studies project tens of thousands of American lives saved annually under universal coverage. However, those estimates come from models rather than experiments, and non-medical factors also drive a large part of the gap.

Which country has the best healthcare system?

The Commonwealth Fund’s Mirror, Mirror 2024 ranked Australia, the Netherlands, and the United Kingdom as the top three performers among 10 wealthy nations. The U.S. ranked last overall, though it placed second on care process quality.

Do Americans wait longer for care than people in universal systems?

Generally no, at least for specialists and elective surgery. Americans typically see specialists faster than Canadians or Britons. Yet Americans more often skip care entirely because of cost, which functions as a different kind of delay.

Is U.S. cancer survival really better?

Five-year survival rates in the U.S. rank among the world’s highest, according to CONCORD-3. Still, heavy screening inflates survival statistics through earlier detection. Cancer mortality per capita offers a more reliable comparison and narrows the gap.

Why is U.S. maternal mortality so high?

Researchers cite high cesarean rates, uneven prenatal care access, chronic conditions such as obesity and diabetes, and a thin midwifery workforce. Racial inequities compound all of these. Black women died at 44.8 per 100,000 live births in 2024.

How many Americans lack health insurance?

Roughly 27 million people, about 8% of the population, held no coverage as of mid-2025. That number is projected to climb following the expiration of enhanced ACA subsidies and recent Medicaid funding changes.

Would universal healthcare raise taxes?

Yes, under a single-payer design. Federal spending would increase substantially because premiums and out-of-pocket costs would move onto the federal budget. Whether households pay more overall depends on how those new taxes compare with the premiums and deductibles they replace.

Does universal healthcare mean government-run hospitals?

Rarely. The U.K. runs hospitals directly, but most universal systems do not. Germany, France, Japan, Switzerland, and the Netherlands rely on private and nonprofit providers paid through public or regulated insurance.

The Bottom Line

The U.S. buys the most expensive health care in the world and receives among the worst population-level results. That contradiction has held for four decades, and the 2026 data reinforces it.

At the same time, the picture resists simple slogans. American care quality ranks near the top once patients get through the door. Universal systems in Canada and the U.K. struggle with waits that Americans would not tolerate.

The most accurate summary runs like this: universal coverage reliably fixes affordability and financial risk. It improves access-related mortality. However, it does not automatically fix capacity, and it cannot touch the overdoses, firearms, and chronic disease that drive much of the American gap. Any serious reform has to address both halves of the problem.

Sources

1. OECD, Health at a Glance 2025: United States Country Note — oecd.org
2. Commonwealth Fund, U.S. Health Care from a Global Perspective, 2026 (May 2026) — commonwealthfund.org
3. Commonwealth Fund, Mirror, Mirror 2024: A Portrait of the Failing U.S. Health System — commonwealthfund.org
4. CDC/NCHS, Mortality in the United States, 2024, Data Brief No. 548 (January 2026) — cdc.gov
5. CDC/NCHS, Maternal Mortality Rates in the United States, 2024, Health E-Stat 113 (March 2026) — cdc.gov
6. Papanicolas I, Niksch M, Figueroa JF, “Avoidable Mortality Across U.S. States and High-Income Countries,” JAMA Internal Medicine (May 2025)
7. Allemani C, et al., CONCORD-3, The Lancet (2018)
8. Fraser Institute, Waiting Your Turn: Wait Times for Health Care in Canada, 2025 (December 2025)
9. British Medical Association, NHS Backlog Data Analysis (2026) and House of Commons Library, NHS Key Statistics: England (2026)
10. Galvani AP, et al., Projected Economic Gains and Lives Saved Under Universal Healthcare in the United States, medRxiv preprint (July 2026)
11. Galvani AP, et al., “Improving the Prognosis of Health Care in the USA,” The Lancet (2020)
12. Blahous C, Mercatus Center (2018); Urban Institute, From Incremental to Comprehensive Health Reform (2019)
13. Johns Hopkins Bloomberg School of Public Health, A Tale of Two Countries (2024)
14. AAMC, Narrowing the Gap: The Burden of Alcohol, Drugs, and Firearms on U.S. Life Expectancy